Geode Capital Management
RCPI

Geode Capital Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Geode Capital Management’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,699
Closed -$25K – 4231
2015
Q3 		$25K Buy
+31,699
New +$35.3K ﹤0.01% 4078
2015
Q2 		– Sell
-31,665
Closed -$80K – 4047
2015
Q1 		$80K Buy
31,665
+39
+0.1% +$154 ﹤0.01% 3796
2014
Q4 		$143K Buy
31,626
+39
+0.1% +$205 ﹤0.01% 3702
2014
Q3 		$221K Buy
31,587
+3,455
+12% +$34.1K ﹤0.01% 3540
2014
Q2 		$414K Buy
+28,132
New +$488K ﹤0.01% 3240

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.86% 1-Year Est. Return

Geode Capital Management's RCPI Position: Q4 2015 in Review

Geode Capital Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 31,699 shares — an estimated $25K sold.

Geode Capital Management first reported a position in RCPI in Q2 2014 and held it in 5 quarters. The position peaked at $414K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Geode Capital Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Geode Capital Management sold 31,699 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $25K.
  • Geode Capital Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 5 quarters.
  • Geode Capital Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $414K in Q2 2014.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Geode Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.